Ovoca Bio not Affected by Sanctions against Russia;
The Board of Ovoca Bio, an international biopharmaceutical company focusing on women’s health, has issued a statement in response to events in Ukraine and Russia.
Pharmaceuticals, Biotechnology and Life Sciences
The Board of Ovoca Bio, an international biopharmaceutical company focusing on women’s health, has issued a statement in response to events in Ukraine and Russia.
Tollys has entered into a sponsored research agreement with Gustave Roussy.
Oncimmune Holdings has signed a commercial contract with a new top 10 global pharmaceutical company by revenue, initially focusing on the autoantibody profiling of Chronic Inflammatory Demyelinating Polyradiculoneuropathy (“CIDP”).
Medix Biochemica has announced the launch of its refreshed and expanding brand to reflect both the exciting improvements to its offering…
Roche have announced an initial donation of essential medicines to Ukraine, after the country has been violently invaded by Russia.…
MiGenTra, headquartered in Berlin, Germany and MiGenTra Egypt, located with its ‘Facility of the Future’ in Cairo, Egypt, have announced…
Oculis and Accure Therapeutics have announced a licensing agreement granting Oculis exclusive global rights to develop and commercialize ACT-01, a…
Holographyx has been granted a U.S. patent for its Holo-Blister product along with a European Patent for the development of…
HOOKIPA Pharma Inc. (Nasdaq: HOOK), a company developing a new class of immunotherapeutics based on its proprietary arenavirus platform, has…
Airnov Healthcare Packaging is now offering a new and more sustainable version of its DRICARD products to its customers, the…